Melina Fatseas1, Cécile Denis1, Zoé Massida1, Magali Verger2, Pascale Franques-Rénéric1, Marc Auriacombe3. 1. Laboratoire de Psychiatrie/Sanpsy Centre National de la Recherche Scientifique-Unité de Service et de Recherche 3413, Université Bordeaux Segalen, Bordeaux, France; Département d'Addictologie, Centre Hospitalier Universitaire de Bordeaux et Centre Hospitalier Charles Perrens, Bordeaux, France. 2. Laboratoire de Psychiatrie/Sanpsy Centre National de la Recherche Scientifique-Unité de Service et de Recherche 3413, Université Bordeaux Segalen, Bordeaux, France. 3. Laboratoire de Psychiatrie/Sanpsy Centre National de la Recherche Scientifique-Unité de Service et de Recherche 3413, Université Bordeaux Segalen, Bordeaux, France; Département d'Addictologie, Centre Hospitalier Universitaire de Bordeaux et Centre Hospitalier Charles Perrens, Bordeaux, France. Electronic address: marc.auriacombe@labopsy.u-bordeaux2.fr.
Abstract
BACKGROUND: Environmental stimuli associated with drug taking have been known to elicit drug craving and physiologic arousal, as well as hypothalamic-pituitary-adrenal axis activation. However, the relationship between these responses and substance use outcomes in heroin-dependent subjects has not been previously studied. We investigated the relationship among subjective and physiologic reactivity, biological stress response evoked in the laboratory, and relapse to substance use in treated opiate-dependent individuals. METHODS: Eighteen opiate-abstinent methadone- or buprenorphine-treated patients and 13 control subjects were exposed to neutral- and drug-cue exposure laboratory sessions with a 3-month follow-up period. Exposure to cues involved both videotapes and handling during a 100-min session. Subjective craving, agonistic effects, withdrawal feelings, galvanic skin resistance, and salivary cortisol were assessed. Substance use outcome among patients was examined during the follow-up phase. Differences between relapsers, nonrelapsers, and controls were analyzed with respect to the data on drug-cue responsivity and on cortisol responses using repeated-measures analysis of variance. The association with substance use outcome was assessed using a nominal logistic model. RESULTS: Relapsers experienced greater drug-cue induced subjective responses and an increased cortisol response compared with both nonrelapsers and control subjects. After adjusting on covariates, cue-induced cortisol response was associated with the relapser group and was highly correlated with self-reports of "high." CONCLUSIONS: Subjects defined as relapsers presented a higher cue-induced reactivity during the drug-cue exposure as well as an increased cortisol response to drug cues. Higher cortisol response to drug cues may increase relapse vulnerability in stable-dose buprenorphine or methadone-maintained subjects.
BACKGROUND: Environmental stimuli associated with drug taking have been known to elicit drug craving and physiologic arousal, as well as hypothalamic-pituitary-adrenal axis activation. However, the relationship between these responses and substance use outcomes in heroin-dependent subjects has not been previously studied. We investigated the relationship among subjective and physiologic reactivity, biological stress response evoked in the laboratory, and relapse to substance use in treated opiate-dependent individuals. METHODS: Eighteen opiate-abstinent methadone- or buprenorphine-treated patients and 13 control subjects were exposed to neutral- and drug-cue exposure laboratory sessions with a 3-month follow-up period. Exposure to cues involved both videotapes and handling during a 100-min session. Subjective craving, agonistic effects, withdrawal feelings, galvanic skin resistance, and salivary cortisol were assessed. Substance use outcome among patients was examined during the follow-up phase. Differences between relapsers, nonrelapsers, and controls were analyzed with respect to the data on drug-cue responsivity and on cortisol responses using repeated-measures analysis of variance. The association with substance use outcome was assessed using a nominal logistic model. RESULTS: Relapsers experienced greater drug-cue induced subjective responses and an increased cortisol response compared with both nonrelapsers and control subjects. After adjusting on covariates, cue-induced cortisol response was associated with the relapser group and was highly correlated with self-reports of "high." CONCLUSIONS: Subjects defined as relapsers presented a higher cue-induced reactivity during the drug-cue exposure as well as an increased cortisol response to drug cues. Higher cortisol response to drug cues may increase relapse vulnerability in stable-dose buprenorphine or methadone-maintained subjects.
Authors: Laura Brandt; Jermaine D Jones; Suky Martinez; Jeanne M Manubay; Shanthi Mogali; Tatiana Ramey; Frances R Levin; Sandra D Comer Journal: Drug Alcohol Depend Date: 2020-01-17 Impact factor: 4.492
Authors: Alex F Manini; Georgia Yiannoulos; Mateus M Bergamaschi; Stephanie Hernandez; Ruben Olmedo; Allan J Barnes; Gary Winkel; Rajita Sinha; Didier Jutras-Aswad; Marilyn A Huestis; Yasmin L Hurd Journal: J Addict Med Date: 2015 May-Jun Impact factor: 3.702
Authors: Sudie E Back; Daniel F Gros; Jenna L McCauley; Julianne C Flanagan; Elizabeth Cox; Kelly S Barth; Kathleen T Brady Journal: Addict Behav Date: 2014-04-12 Impact factor: 3.913
Authors: Paul S Regier; Zachary A Monge; Teresa R Franklin; Reagan R Wetherill; Anne Teitelman; Kanchana Jagannathan; Jesse J Suh; Ze Wang; Kimberly A Young; Michael Gawrysiak; Daniel D Langleben; Kyle M Kampman; Charles P O'Brien; Anna Rose Childress Journal: Addict Biol Date: 2016-09-22 Impact factor: 4.280
Authors: Evan N Graf; Robert A Wheeler; David A Baker; Amanda L Ebben; Jonathan E Hill; Jayme R McReynolds; Mykel A Robble; Oliver Vranjkovic; Daniel S Wheeler; John R Mantsch; Paul J Gasser Journal: J Neurosci Date: 2013-07-17 Impact factor: 6.167